Morphine-induced mu-opioid receptor rapid desensitization is independent of receptor phosphorylation and beta-arrestins

Author(s): Chu J, Zheng H, Loh HH, Law PY

Abstract

Receptor desensitization involving receptor phosphorylation and subsequent betaArrestin (betaArr) recruitment has been implicated in the tolerance development mediated by mu-opioid receptor (OPRM1). However, the roles of receptor phosphorylation and betaArr on morphine-induced OPRM1 desensitization remain to be demonstrated. Using OPRM1-induced intracellular Ca(2+) ([Ca(2+)](i))release to monitor receptor activation, as predicted, [D-Ala(2), N-Me-Phe(4), Gly(5)-ol]-enkephalin (DAMGO), induced OPRM1 desensitization in a receptor phosphorylation- and betaArr-dependent manner. The DAMGO-induced OPRM1 desensitization was attenuated significantly when phosphorylation deficient OPRM1 mutants or Mouse Embryonic Fibroblast (MEF) cells from betaArr1 and 2 knockout mice were used in the studies. Specifically, DAMGO-induced desensitization was blunted in HEK293 cells expressing the OPRM1S375A mutant and was eliminated in MEF cells isolated from betaArr2 knockout mice expressing the wild type OPRM1. However, although morphine also could induce a rapid desensitization on [Ca(2+)](i) release to a greater extent than that of DAMGO and could induce the phosphorylation of Ser(375) residue, morphine-induced desensitization was not influenced by mutating the phosphorylation sites or in MEF cells lacking betaArr1 and 2. Hence, morphine could induce OPRM1 desensitization via pathway independent of betaArr, thus suggesting the in vivo tolerance development to morphine can occur in the absence of betaArr.

Similar Articles

Enhanced morphine analgesia in mice lacking beta-arrestin 2

Author(s): Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, et al.

Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence

Author(s): Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG, et al.

Ligand-directed signalling within the opioid receptor family

Author(s): Pradhan AA, Smith ML, Kieffer BL, Evans CJ

μ-opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization

Author(s): McPherson J, Rivero G, Baptist M, Llorente J, Al-Sabah S, et al.

Morphine-like opiates selectively antagonize receptor-arrestin interactions

Author(s): Molinari P, Vezzi V, Sbraccia M, Grò C, Riitano D, et al.

Pharmacological characterization of AR-M1000390 at human delta opioid receptors

Author(s): Marie N, Landemore G, Debout C, Jauzac P, Allouche S

SK-N-BE: a human neuroblastoma cell line containing two subtypes of delta-opioid receptors

Author(s): Polastron J, Mur M, Mazarguil H, Puget A, Meunier JC, et al.

ßarrestin1-biased agonism at human δ-opioid receptor by peptidic and alkaloid ligands

Author(s): Aguila B, Coulbault L, Davis A, Marie N, Hasbi A, et al.

Molecular control of δ-opioid receptor signalling

Author(s): Fenalti G, Giguere PM, Katritch V, Huang XP, Thompson AA, et al.

Development and validation of a genetic algorithm for flexible docking

Author(s): Jones G, Willett P, Glen RC, Leach AR, Taylor R, et al.

Agonist-selective mechanisms of GPCR desensitization

Author(s): Kelly E, Bailey CP, Henderson G

Recovery from mu-opioid receptor desensitization after chronic treatment with morphine and methadone

Author(s): Quillinan N, Lau EK, Virk M, von Zastrow M, Williams JT

Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes

Author(s): Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, et al.